drugset / Trial / NCT01106807
Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of the study is to evaluate the efficacy of CD07223 1.5% Gel and 0.5% gel in reducing inflammatory, non-inflammatory, and total acne lesion counts after 6 weeks of twice daily applications. The study will also evaluate the safety of the study products using tolerance and adverse event data.
Timeline
- Start
- 2010-04
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Adapalene | Other / unclassified | 0.1 % | Topical |
| Comparator | Benzoyl Peroxide | Other / unclassified | 2.5 % | Topical |
| Subject | CD07223 | Unknown | 0.5 % | Topical |
| Subject | CD07223 | Unknown | 1.5 % | Topical |